[go: up one dir, main page]

IS5046A - Lyfjasamsetningar - Google Patents

Lyfjasamsetningar

Info

Publication number
IS5046A
IS5046A IS5046A IS5046A IS5046A IS 5046 A IS5046 A IS 5046A IS 5046 A IS5046 A IS 5046A IS 5046 A IS5046 A IS 5046A IS 5046 A IS5046 A IS 5046A
Authority
IS
Iceland
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IS5046A
Other languages
English (en)
Inventor
Bell-Huff Cristi
Francis Dolan Thomas
Carol Gatlin Hausberger Angela
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS5046A publication Critical patent/IS5046A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicon Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5046A 1998-05-15 1999-05-07 Lyfjasamsetningar IS5046A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8564698P 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
IS5046A true IS5046A (is) 1999-11-16

Family

ID=22193027

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5046A IS5046A (is) 1998-05-15 1999-05-07 Lyfjasamsetningar

Country Status (32)

Country Link
US (1) US20020002172A1 (is)
EP (1) EP0960621A3 (is)
JP (1) JPH11349483A (is)
KR (1) KR19990088249A (is)
CN (1) CN1251758A (is)
AP (1) AP9901534A0 (is)
AR (1) AR016481A1 (is)
AU (1) AU753478B2 (is)
BG (1) BG103396A (is)
BR (1) BR9902086A (is)
CA (1) CA2272042A1 (is)
CO (1) CO5060503A1 (is)
DZ (1) DZ2786A1 (is)
EA (1) EA002830B1 (is)
GT (1) GT199900061A (is)
HN (1) HN1999000066A (is)
HR (1) HRP990144A2 (is)
HU (1) HUP9901606A2 (is)
ID (1) ID23299A (is)
IS (1) IS5046A (is)
MA (1) MA26629A1 (is)
NO (1) NO992339L (is)
NZ (1) NZ335772A (is)
OA (1) OA11040A (is)
PA (1) PA8472901A1 (is)
PE (1) PE20000546A1 (is)
PL (1) PL333118A1 (is)
SG (1) SG79255A1 (is)
SK (1) SK61599A3 (is)
TR (1) TR199901077A2 (is)
YU (1) YU21999A (is)
ZA (1) ZA993338B (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743443B1 (en) * 1998-10-05 2004-06-01 Eisai Co., Ltd. Tablets immediately disintegrating in the oral cavity
EP1161255A4 (en) * 1999-03-08 2002-07-17 Merck & Co Inc METHOD AND MEANS FOR TREATING ERECTILE DYSFUNCTION
EP1171134A4 (en) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
ES2381862T3 (es) 2000-09-06 2012-06-01 Mitsubishi Tanabe Pharma Corporation Preparaciones para administración por vía oral
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (is) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
CN1284532C (zh) * 2001-09-28 2006-11-15 株式会社三和化学研究所 有核型速溶崩解性成型品
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
KR100974482B1 (ko) 2003-03-27 2010-08-10 가부시키가이샤 바이오악티스 비강용 분말 약제 투약 장치
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US8673360B2 (en) * 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
MX2008000087A (es) * 2005-06-23 2008-03-18 Schering Corp Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5.
RU2435588C2 (ru) * 2005-09-29 2011-12-10 Байер Шеринг Фарма Акциенгезельшафт Ингибиторы фдэ и их комбинации для лечения урологических расстройств
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
US20080261991A1 (en) * 2007-02-12 2008-10-23 Dmi Biosciences, Inc. Reducing Side Effects of Tramadol
CA2689638A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
FR2932682B1 (fr) * 2008-06-23 2013-07-12 Bionetwork Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
KR101817361B1 (ko) * 2009-03-09 2018-01-11 에스피아이 파르마, 인크. 고도 압착성 및 내구성 직접 압축성 부형제 및 부형제 시스템
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US8827946B2 (en) * 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
EP2338474A1 (de) 2009-12-23 2011-06-29 Ratiopharm GmbH Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
MA34960B1 (fr) * 2011-02-11 2014-03-01 Ctc Bio Inc Preparation de film contenant une base sans sidenafil et son procede
KR101418406B1 (ko) * 2011-08-24 2014-07-10 한미약품 주식회사 실데나필 유리 염기를 포함하는 구강 붕해정
MX366768B (es) * 2011-12-08 2019-07-17 Laboratorios Liomont S A De C V Tableta orodispersable de sildenafil y metodo para preparar la misma.
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN114246835A (zh) * 2022-01-05 2022-03-29 河北龙海药业有限公司 一种枸橼酸西地那非口腔崩解片的制备方法
WO2025048919A1 (en) * 2023-08-30 2025-03-06 Dow Global Technologies Llc Spray dried excipient blends

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE19532142A1 (de) * 1995-08-31 1997-03-06 Siemens Ag Verfahren und Vorrichtung zur Regelung eines vierdimensionalen Vektors einer Strecke mittels eines wertediskreten Stellgliedes mit begrenzter Schaltfrequenz
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
KR20010012995A (ko) * 1997-05-29 2001-02-26 모치다 에이 발기부전 치료제
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
EP1171134A4 (en) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL

Also Published As

Publication number Publication date
TR199901077A3 (tr) 1999-12-21
NZ335772A (en) 2000-12-22
SK61599A3 (en) 2000-12-11
HRP990144A2 (en) 2000-02-29
GT199900061A (es) 2000-10-14
SG79255A1 (en) 2001-03-20
TR199901077A2 (en) 1999-12-21
HUP9901606A2 (en) 2002-09-28
PL333118A1 (en) 1999-11-22
BR9902086A (pt) 2000-05-02
AU2812699A (en) 1999-11-25
NO992339D0 (no) 1999-05-14
AU753478B2 (en) 2002-10-17
KR19990088249A (ko) 1999-12-27
NO992339L (no) 1999-11-16
EP0960621A2 (en) 1999-12-01
PA8472901A1 (es) 2000-09-29
ZA993338B (en) 2000-11-14
EA199900373A2 (ru) 1999-12-29
US20020002172A1 (en) 2002-01-03
HU9901606D0 (en) 1999-07-28
AP9901534A0 (en) 1999-06-30
EA002830B1 (ru) 2002-10-31
HN1999000066A (es) 1999-09-29
BG103396A (bg) 2000-01-31
CA2272042A1 (en) 1999-11-15
PE20000546A1 (es) 2000-07-07
CN1251758A (zh) 2000-05-03
EP0960621A3 (en) 2000-01-05
MA26629A1 (fr) 2004-12-20
DZ2786A1 (fr) 2003-12-01
ID23299A (id) 2000-04-05
YU21999A (sh) 2002-03-18
CO5060503A1 (es) 2001-07-30
OA11040A (en) 2003-01-01
AR016481A1 (es) 2001-07-04
EA199900373A3 (ru) 2000-08-28
JPH11349483A (ja) 1999-12-21

Similar Documents

Publication Publication Date Title
IS5046A (is) Lyfjasamsetningar
ID27415A (id) Komposisi farmaseutik
NO20005913D0 (no) Legemiddelsammensetning
PT1242087E (pt) Composicoes farmaceuticas
NO20015175D0 (no) Farmasöytisk sammensetning
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI991485L (fi) Uusi farmaseuttinen koostumus
ID29262A (id) Komposisi farmasi
ATE469550T1 (de) Antiparasitäre zusammensetzungen
ID18352A (id) Komposisi-komposisi farmasi
DE69935172D1 (de) Imidosilan Zusammensetzungen
FI991302L (fi) Parannetut farmaseuttiset koostumukset
ID27201A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
PT1239832E (pt) Composicoes farmaceuticas
IS2515B (is) Lyfjasamsetningar
ID30032A (id) Formulasi farmasi
FI4488U1 (fi) Farmaseuttinen koostumus
PT941100E (pt) Composicoes farmaceuticas
EE200000330A (et) Farmatseutilised kompositsioonid
PT1051156E (pt) Composicoes farmaceuticas
NO994436L (no) Farmasöytiske sammensetninger
SE9800052D0 (sv) Pharmaceutical compositions